{"id":"https://openalex.org/W3140100778","doi":"https://doi.org/10.1158/1535-7163.mct-21-0077","title":"Expanding the Repertoire for \u201cLarge Small Molecules\u201d: Prodrug ABBV-167 Efficiently Converts to Venetoclax with Reduced Food Effect in Healthy Volunteers","display_name":"Expanding the Repertoire for \u201cLarge Small Molecules\u201d: Prodrug ABBV-167 Efficiently Converts to Venetoclax with Reduced Food Effect in Healthy Volunteers","publication_year":2021,"publication_date":"2021-03-30","ids":{"openalex":"https://openalex.org/W3140100778","doi":"https://doi.org/10.1158/1535-7163.mct-21-0077","mag":"3140100778","pmid":"https://pubmed.ncbi.nlm.nih.gov/33785651"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-21-0077","doi":"https://doi.org/10.1158/1535-7163.mct-21-0077","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-21-0077","pdf_url":"https://aacrjournals.org/mct/article-pdf/20/6/999/3104113/999.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/20/6/999/3104113/999.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053884536","display_name":"Ahmed Hamed Salem","orcid":"https://orcid.org/0000-0002-9261-1583","observed_orcids":["https://orcid.org/0000-0002-9261-1583"]},"institutions":[{"id":"https://openalex.org/I107720978","display_name":"Ain Shams University","ror":"https://ror.org/00cb9w016","country_code":"EG","type":"education","lineage":["https://openalex.org/I107720978"]},{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["EG","US"],"is_corresponding":false,"raw_author_name":"Ahmed Hamed Salem","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois","2Ain Shams University, Cairo, Egypt"],"raw_orcid":"https://orcid.org/0000-0002-9261-1583","affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"2Ain Shams University, Cairo, Egypt","institution_ids":["https://openalex.org/I107720978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065873347","display_name":"Zhi\u2010Fu Tao","orcid":"https://orcid.org/0000-0001-5040-2444","observed_orcids":["https://orcid.org/0000-0001-5040-2444"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhi-Fu Tao","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075495406","display_name":"Orlando Felix Bueno","orcid":"https://orcid.org/0009-0009-9513-3941","observed_orcids":["https://orcid.org/0009-0009-9513-3941"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Orlando F. Bueno","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100332989","display_name":"Jie Chen","orcid":"https://orcid.org/0000-0003-0035-9649","observed_orcids":["https://orcid.org/0000-0003-0035-9649"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jie Chen","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0003-0035-9649","affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shuang Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuang Chen","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074125601","display_name":"Rohinton P. Edalji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rohinton Edalji","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108529517","display_name":"Steven W. Elmore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven W. Elmore","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051723932","display_name":"Keith M. Fournier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith M. Fournier","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055605641","display_name":"Kaid C. Harper","orcid":"https://orcid.org/0000-0003-3894-4851","observed_orcids":["https://orcid.org/0000-0003-3894-4851"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaid C. Harper","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056737382","display_name":"Richard S. Hong","orcid":"https://orcid.org/0000-0002-4214-6847","observed_orcids":["https://orcid.org/0000-0002-4214-6847"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Hong","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030969252","display_name":"Gary J. Jenkins","orcid":"https://orcid.org/0009-0004-4585-8542","observed_orcids":["https://orcid.org/0009-0004-4585-8542"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary J. Jenkins","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042477286","display_name":"Jianguo Ji","orcid":"https://orcid.org/0000-0002-7863-4789","observed_orcids":["https://orcid.org/0000-0002-7863-4789"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianguo Ji","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016022019","display_name":"Russell A. Judge","orcid":"https://orcid.org/0000-0001-5917-9269","observed_orcids":["https://orcid.org/0000-0001-5917-9269"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell A. Judge","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0001-5917-9269","affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057541429","display_name":"J. Cory Kalvass","orcid":"https://orcid.org/0000-0003-4414-2804","observed_orcids":["https://orcid.org/0000-0003-4414-2804"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Kalvass","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000765096","display_name":"Russell C. Klix","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell C. Klix","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045234198","display_name":"Yi\u2010Yin Ku","orcid":"https://orcid.org/0000-0002-9833-2614","observed_orcids":["https://orcid.org/0000-0002-9833-2614"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi-Yin Ku","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-9833-2614","affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088427493","display_name":"Joel D. Leverson","orcid":"https://orcid.org/0000-0003-1162-724X","observed_orcids":["https://orcid.org/0000-0003-1162-724X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel D. Leverson","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard A. Marks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Marks","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026852803","display_name":"Kennan C. Marsh","orcid":"https://orcid.org/0000-0001-5076-4234","observed_orcids":["https://orcid.org/0000-0001-5076-4234"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kennan C. Marsh","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082324800","display_name":"Rajeev M Menon","orcid":"https://orcid.org/0000-0002-2945-0449","observed_orcids":["https://orcid.org/0000-0002-2945-0449"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajeev M. Menon","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038244916","display_name":"Chang H. Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chang H. Park","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019593738","display_name":"Darren C. Phillips","orcid":"https://orcid.org/0009-0000-6760-9759","observed_orcids":["https://orcid.org/0009-0000-6760-9759"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darren C. Phillips","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108479102","display_name":"Yu\u2010Ming Pu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu-Ming Pu","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111940687","display_name":"Saul H. Rosenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saul H. Rosenberg","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023463690","display_name":"Yeshwant D. Sanzgiri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yeshwant D. Sanzgiri","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041496759","display_name":"Ahmad Y. Sheikh","orcid":"https://orcid.org/0000-0002-5972-3938","observed_orcids":["https://orcid.org/0000-0002-5972-3938"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Y. Sheikh","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-5972-3938","affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057946510","display_name":"Yi Shi","orcid":"https://orcid.org/0000-0003-2254-6541","observed_orcids":["https://orcid.org/0000-0003-2254-6541"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi Shi","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062433859","display_name":"DeAnne F. Stolarik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deanne Stolarik","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021168706","display_name":"Ahmed A. Suleiman","orcid":"https://orcid.org/0000-0001-8499-6316","observed_orcids":["https://orcid.org/0000-0001-8499-6316"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed A. Suleiman","raw_affiliation_strings":["3AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045733425","display_name":"Xilu Wang","orcid":"https://orcid.org/0000-0001-9846-5751","observed_orcids":["https://orcid.org/0000-0001-9846-5751"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xilu Wang","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019910492","display_name":"Geoff G. Z. Zhang","orcid":"https://orcid.org/0000-0001-5527-2781","observed_orcids":["https://orcid.org/0000-0001-5527-2781"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoff G.Z. Zhang","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034778721","display_name":"Nathaniel D. Catron","orcid":"https://orcid.org/0009-0004-5057-1036","observed_orcids":["https://orcid.org/0009-0004-5057-1036"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathaniel D. Catron","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017976189","display_name":"Andrew James Souers","orcid":"https://orcid.org/0009-0002-5965-0633","observed_orcids":["https://orcid.org/0009-0002-5965-0633"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew J. Souers","raw_affiliation_strings":["1AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017976189"],"corresponding_institution_ids":["https://openalex.org/I2948539688"],"apc_list":null,"apc_paid":null,"fwci":2.2442,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.8817767,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"20","issue":"6","first_page":"999","last_page":"1008"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.7559000253677368,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.7559000253677368,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.23180000483989716,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9929999709129333},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.7360000014305115},{"id":"https://openalex.org/keywords/phosphate-prodrugs","display_name":"phosphate prodrugs","score":0.8309999704360962},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.8690000176429749},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8640000224113464},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.6869999766349792},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8550000190734863},{"id":"https://openalex.org/keywords/water-solubility-enhancement","display_name":"aqueous solubility enhancement","score":0.8320000171661377},{"id":"https://openalex.org/keywords/rule-of-5","display_name":"Rule of 5","score":0.47200000286102295},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.531000018119812},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9808746576309204},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9163575172424316},{"id":"https://openalex.org/C201399114","wikidata":"https://www.wikidata.org/wiki/Q898401","display_name":"Lipophilicity","level":2,"score":0.6104294061660767},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6060618162155151},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5020315647125244},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4786045253276825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46918702125549316},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.44271084666252136},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43236014246940613},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2976086735725403},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.24726855754852295},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23578855395317078},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.1489730179309845}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-21-0077","doi":"https://doi.org/10.1158/1535-7163.mct-21-0077","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-21-0077","pdf_url":"https://aacrjournals.org/mct/article-pdf/20/6/999/3104113/999.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:33785651","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33785651","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-21-0077","doi":"https://doi.org/10.1158/1535-7163.mct-21-0077","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-21-0077","pdf_url":"https://aacrjournals.org/mct/article-pdf/20/6/999/3104113/999.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","score":0.4099999964237213,"display_name":"Zero hunger"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3140100778.pdf","grobid_xml":"https://content.openalex.org/works/W3140100778.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1822606120","https://openalex.org/W1977258127","https://openalex.org/W2003594967","https://openalex.org/W2008757142","https://openalex.org/W2034269086","https://openalex.org/W2082689579","https://openalex.org/W2111988922","https://openalex.org/W2148659963","https://openalex.org/W2150048195","https://openalex.org/W2156829937","https://openalex.org/W2171219272","https://openalex.org/W2172242534","https://openalex.org/W2213042592","https://openalex.org/W2328549977","https://openalex.org/W2401424021","https://openalex.org/W2409945629","https://openalex.org/W2409989837","https://openalex.org/W2605628453","https://openalex.org/W2692768525","https://openalex.org/W2742919542","https://openalex.org/W2756205407","https://openalex.org/W2770858121","https://openalex.org/W2801859295","https://openalex.org/W2901786533","https://openalex.org/W2902257786","https://openalex.org/W2979317446","https://openalex.org/W2983550980","https://openalex.org/W2995135594","https://openalex.org/W2997061680","https://openalex.org/W3012836383","https://openalex.org/W3049409940","https://openalex.org/W4250053631"],"related_works":["https://openalex.org/W7134889470","https://openalex.org/W2328549977","https://openalex.org/W2514200009","https://openalex.org/W1970329726","https://openalex.org/W7078902968","https://openalex.org/W4398194351","https://openalex.org/W4398253270","https://openalex.org/W3200818535","https://openalex.org/W2620976413","https://openalex.org/W2267866810"],"abstract_inverted_index":{"Abstract":[0],"Since":[1],"gaining":[2],"approval":[3],"for":[4,77],"the":[5,12,18,27,118,155],"treatment":[6,19],"of":[7,20,154],"chronic":[8],"lymphocytic":[9],"leukemia":[10],"(CLL),":[11],"BCL-2":[13],"inhibitor":[14],"venetoclax":[15,35,63,97,131],"has":[16,36],"transformed":[17],"this":[21],"and":[22,29,41,69],"other":[23],"blood-related":[24],"cancers.":[25],"Reflecting":[26],"large":[28],"hydrophobic":[30],"BH3-binding":[31],"groove":[32],"within":[33],"BCL-2,":[34],"significantly":[37,92],"higher":[38],"molecular":[39],"weight":[40],"lipophilicity":[42],"than":[43],"most":[44],"orally":[45],"administered":[46],"drugs,":[47],"along":[48],"with":[49,128],"negligible":[50],"water":[51,94],"solubility.":[52],"Although":[53],"a":[54,73,85,107,124,146],"technology-enabled":[55],"formulation":[56],"successfully":[57,141],"achieves":[58],"oral":[59,100,159],"absorption":[60],"in":[61,79],"humans,":[62],"tablets":[64],"have":[65],"limited":[66],"drug":[67,157],"loading":[68],"therefore":[70,83],"can":[71,139],"present":[72],"substantial":[74],"pill":[75],"burden":[76],"patients":[78],"high-dose":[80],"indications.":[81],"We":[82],"generated":[84],"phosphate":[86],"prodrug":[87,148],"(3,":[88],"ABBV-167)":[89],"that":[90,136],"confers":[91],"increased":[93],"solubility":[95],"to":[96,102,117,130,143,150],"and,":[98],"upon":[99],"administration":[101],"healthy":[103],"volunteers":[104],"either":[105],"as":[106],"solution":[108],"or":[109],"high":[110],"drug-load":[111],"immediate":[112],"release":[113],"tablet,":[114],"extensively":[115],"converts":[116],"parent":[119,156],"drug.":[120],"Additionally,":[121],"ABBV-167":[122],"demonstrated":[123],"lower":[125],"food":[126],"effect":[127],"respect":[129],"tablets.":[132],"These":[133],"data":[134],"indicate":[135],"beyond-rule-of-5":[137],"molecules":[138],"be":[140],"delivered":[142],"humans":[144],"via":[145],"solubility-enhancing":[147],"moiety":[149],"afford":[151],"robust":[152],"exposures":[153],"following":[158],"dosing.":[160]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-04-13T00:00:00"}